Tolerability and Toxicity of Topically Applied Nepafenac 0.3% vs Ketorolac 0.5%

NCT02752646 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Cataract

Interventions

DRUG: nepafenac 0.3%
DRUG: ketorolac

Sponsor

MDbackline, LLC

Collaborators

[object Object]